Global X Defense Tech ETF vs Stryker Corporation — how do they compare? Global X Defense Tech ETF trades at $59.87 (market cap $6.29B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 16.9× Global X Defense Tech ETF's market cap, and Stryker Corporation pays a 1.27% dividend while Global X Defense Tech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Defense Tech ETF for 44 Days and Stryker Corporation for 21 Days on average.
| SHLD | SYK | |
|---|---|---|
Market Cap | $6.29B | $106.24B |
Volume | 1,133,252 | 2,982,001 |
Sector | Sector/Thematic | Health |
52-Week High | $78.02 | $388.35 |
52-Week Low | $58.20 | $269.75 |
Typical Hold Time | 44 Days | 21 Days |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
SHLD (Global X Defense Tech ETF) trades at $59.87, up 1.92% today, but technical indicators show a bearish trend with moving averages signaling strong selling pressure. The ETF focuses on defense technology with exposure to global defense firms, benefiting from increased defense spending trends. Recent institutional buying activity indicates growing investor interest in the defense sector.
The outlook for SHLD appears mixed - strong geopolitical tailwinds support defense spending growth, but technical weakness suggests near-term pressure. Key opportunities include exposure to rising global defense budgets, while risks involve sector volatility and geopolitical uncertainties affecting defense stocks.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →